TRIV-573 is a preclinical bispecific antibody designed to target KLK5/7 and interleukin IL-13….
Read More…
Source: https://www.pharmaceutical-technology.com/news/triveni-scores-115m-to-expand-immunology-pipeline/
Just another SmallNews Site
TRIV-573 is a preclinical bispecific antibody designed to target KLK5/7 and interleukin IL-13….
Read More…
Source: https://www.pharmaceutical-technology.com/news/triveni-scores-115m-to-expand-immunology-pipeline/